Rockefeller Capital Management
OLMA icon

Rockefeller Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Rockefeller Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.42K Sell
353
-393
-53% -$5.26K ﹤0.01% 4271
2026
Q1 		$11.1K Buy
746
+596
+397% +$13.3K ﹤0.01% 3954
2025
Q4 		$3.75K Buy
+150
New +$2.67K ﹤0.01% 4152

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Rockefeller Capital Management's OLMA Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Olema Pharmaceuticals (OLMA) stake by 53% in Q2 2026, selling an estimated $5.26K and leaving 353 shares worth $4.42K. The position accounts for ﹤0.01% of the portfolio, ranked #4271.

Rockefeller Capital Management first reported a position in OLMA in Q4 2025 and has held it in 3 quarters since. The position peaked at $11.1K in Q1 2026. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Rockefeller Capital Management held 353 shares of Olema Pharmaceuticals worth $4.42K as of Q2 2026.
  • Rockefeller Capital Management sold 393 Olema Pharmaceuticals shares in Q2 2026, an estimated $5.26K.
  • Olema Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4271 holding.
  • Rockefeller Capital Management first reported a position in Olema Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Rockefeller Capital Management's Olema Pharmaceuticals position peaked at $11.1K in Q1 2026.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.